Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial

he potential of mobile health (mHealth) technology combining telemonitoring and teleintervention as a non-invasive intervention to reduce the risk of cardiovascular events in patients with heart failure during the early post-discharge period (ie, the vulnerable phase) has not been evaluated to our k...

Descripción completa

Detalles Bibliográficos
Autores: Yun, Sergi, Comín Colet, J., Calero Molina, Esther, Hidalgo, Encarnación, José Bazán, Núria, Cobo Marcos, Marta, Soria, Teresa, Llácer, Pau, Fernández, Cristina, García Pinilla, José Manuel, Cruzado, Concepción, Juan Bagudá, Javier de, Et.al.
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:inglés
OAI Identifier:oai:abacus.universidadeuropea.com:11268/16390
Acceso en línea:https://hdl.handle.net/11268/16390
Access Level:acceso abierto
Palabra clave:Telemedicina
Infarto del Miocardio
Ensayo Clínico Controlado Aleatorio
Sistema cardiovascular
Investigación médica
Goal 3: Ensure healthy lives and promote well-being for all at all ages
Descripción
Sumario:he potential of mobile health (mHealth) technology combining telemonitoring and teleintervention as a non-invasive intervention to reduce the risk of cardiovascular events in patients with heart failure during the early post-discharge period (ie, the vulnerable phase) has not been evaluated to our knowledge. We investigated the efficacy of incorporating mHealth into routine heart failure management in vulnerable-phase patients.

Similares en LA Referencia